| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 09/18/2002 | EP1241258A2 Stem cell factor |
| 09/18/2002 | EP1241257A1 Novel tachykinin-like polypeptides and use thereof |
| 09/18/2002 | EP1241255A1 Novel human rna helicase, helicain |
| 09/18/2002 | EP1241253A1 HUMAN PROTEINS BINDING TO HUMAN TYROSINE KINASE Hck AND GENES ENCODING THE SAME |
| 09/18/2002 | EP1241248A1 Method of proliferating a microorganism capable of degrading a hard-to-degrade organic compound and use thereof |
| 09/18/2002 | EP1241246A1 Process for producing l-amino acid and novel gene |
| 09/18/2002 | EP1241182A2 Analysis of agonist-activity and antagonist-activity to cytokinin receptor |
| 09/18/2002 | EP1240526A2 Conformational and topological protein regulation |
| 09/18/2002 | EP1240339A1 Double selection vector |
| 09/18/2002 | EP1240338A2 Production of heterologous proteins |
| 09/18/2002 | EP1240336A2 Enzymes and genes used for producing vanillin |
| 09/18/2002 | EP1240335A2 Proteases |
| 09/18/2002 | EP1240334A2 Core 1b3-galactosyl transferases and methods of use thereof |
| 09/18/2002 | EP1240332A2 Streptococcus pyogenes virulence genes and proteins and their use |
| 09/18/2002 | EP1240331A2 i CHLAMYDIA /i ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 09/18/2002 | EP1240330A2 i PSEUDOMONAS AERUGINOSA /i ANTIGENS |
| 09/18/2002 | EP1240329A2 i STREPTOCOCCUS PNEUMONIAE /i ANTIGENS |
| 09/18/2002 | EP1240328A1 Antigenic protein lppq of mycoplasma mycoides subsp. mycoides sc., its preparation and use |
| 09/18/2002 | EP1240327A2 Interferon-like molecules and uses thereof |
| 09/18/2002 | EP1240319A1 Shotgun scanning, a combinatorial method for mapping functional protein epitopes |
| 09/18/2002 | EP1240316A2 Resolvase-catalysed, sequence-specific dna-recombination in eukaryotic cells |
| 09/18/2002 | EP1240313A2 Homologues of human heparanase and splice variants thereof |
| 09/18/2002 | EP1240311A1 Dna molecules encoding human nhl, a dna helicase |
| 09/18/2002 | EP1240202A2 Inhibitors of complement activation, their preparation and use |
| 09/18/2002 | EP1240198A1 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 09/18/2002 | EP1240197A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 09/18/2002 | EP1240196A2 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 09/18/2002 | EP1240195A2 Polynucleotides and polypeptides encoded thereby |
| 09/18/2002 | EP1240194A2 Novel human protein kinases and protein kinase-like enzymes |
| 09/18/2002 | EP1240192A2 Attenuated microorganisms for the treatment of infection |
| 09/18/2002 | EP1240191A1 P. gingivalis antigenic composition |
| 09/18/2002 | EP1240186A2 Improvements in or relating to immune responses to hiv |
| 09/18/2002 | EP1240183A2 Mammalian genes; related reagents and methods |
| 09/18/2002 | EP1240178A2 Methods and materials relating to prothrombinase-like polypeptides and polynucleotides |
| 09/18/2002 | EP1239870A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 09/18/2002 | EP1239869A2 Tweak receptor |
| 09/18/2002 | EP1239813A2 Extract of blue-green alga spirulina and the use thereof in cosmetic and dermatological skin-care and body care agents |
| 09/18/2002 | EP0842267B1 Mch2, AN APOPTOTIC CYSTEINE PROTEASE, AND COMPOSITIONS FOR MAKING AND METHODS OF USING THE SAME |
| 09/18/2002 | EP0789763B1 Icam-4 materials and methods |
| 09/18/2002 | EP0755401B1 Apparatus for isolating cellular components |
| 09/18/2002 | EP0648263B1 Lipases from hyphozyma |
| 09/18/2002 | CN1370239A Streptomyces avermitilis gene directing ratio of B2:B1 avermectins |
| 09/18/2002 | CN1370238A Human poly(ADP-ribose) polymerase 2 materials and methods |
| 09/18/2002 | CN1370232A Methods for making APO-2 ligand using divalent metal ions |
| 09/18/2002 | CN1370231A CASB618 polynucleotides and polypeptides and their use |
| 09/18/2002 | CN1370229A Nucleic acid fragment and vector contg. halogenase and method for halogenation of chemical compounds |
| 09/18/2002 | CN1370228A Process for producing L-lysine |
| 09/18/2002 | CN1370227A Bacterial consortium EBC1000 and method using bacterial consortium EBC 1000 for remedying biologically recalcitrant toxic chemicals contained in industrial wastewater etc. |
| 09/18/2002 | CN1370182A Compounds and methods for therapy and diagnosis of lung cancer |
| 09/18/2002 | CN1370178A Polynucletoides and polypeptides encoded through distantly homogous to heparanase |
| 09/18/2002 | CN1369562A Plant expression carrier with dual insect-resisting genes and its application |
| 09/18/2002 | CN1369554A Glycotransferase trasition expression strain of protean strep to coccus and its configuration process |
| 09/18/2002 | CN1369553A Process for preparing solid active lactobacillus preparation |
| 09/18/2002 | CN1369552A Composite microbial bacterim praparation and leaven and fertilizer prepared from it |
| 09/18/2002 | CN1369551A Hay bacillus for preparing elastase |
| 09/18/2002 | CN1369550A Culture medium of staphylococcus aureus and its preparing process |
| 09/18/2002 | CN1369549A Monjljell bacterial strain for producing erythrose alcohol |
| 09/18/2002 | CN1091151C Common wild-rice near isogenic line resisting bacterial leaf-blight and its breeding process |
| 09/18/2002 | CN1091150C Mortierella Diding CGMCC0346, its isolation cultivation method and fermentation tech method |
| 09/18/2002 | CN1091149C Method for cultivating Chinese caterpillar fungus |
| 09/17/2002 | US6451994 Polypeptides, polynucleotides; drug screening; diagnosing alzheimer*s, parkinson*s, huntington*s, and creutzfelt-jacob disease; amyotrophic lateral sclerosis, cystic fibrosis |
| 09/17/2002 | US6451992 Antithrombin activity; veterinary vaccines |
| 09/17/2002 | US6451981 Inhibitor of cellular adhesion, migration or infiltration into areas of tissue damage, injury, or transplant |
| 09/17/2002 | US6451976 Bi-or multifunctional molecules based on a dendroaspin scaffold |
| 09/17/2002 | US6451597 Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins |
| 09/17/2002 | US6451595 Murine leukemia virus with pol, env, and gag coding regions deleted; gene therapy; gene expression and engineering |
| 09/17/2002 | US6451592 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 09/17/2002 | US6451585 Steps of fabricating cells of micro-organisms capable of degrading hydrocarbons, encapsulating the cells into pods dissolvable in a non-hydrocarbon environment such as water, introducing the pods into a body of petroleum contained in a |
| 09/17/2002 | US6451584 Nutrient broth for use in the propagation of preferential microorgansim and generation of foods |
| 09/17/2002 | US6451582 Staphylococcus strains comprising an inducible gene encoding an RNA polymerase specificity factor |
| 09/17/2002 | US6451579 Regulated expression of recombinant proteins using RNA viruses |
| 09/17/2002 | US6451575 The invention is directed to the family of aggrecan degrading metallo proteases (admps) that exhibit the ability to cleave the aggrecan core protein between amino acid residues glu.sup.373 -ala.sup.374. the invention encompasses the |
| 09/17/2002 | US6451567 Growing of the microflora in fermentation medium containing nonchloride containing sodium salts, in particular sodium sulfate. the process produces microflora having a cell aggregate size useful for the production of food products for |
| 09/17/2002 | US6451566 Method for producing dihydroxyacetone-3-phosphate |
| 09/17/2002 | US6451565 Method of producing γ-decalactone using Yarrowia lipolytica strain HR 145 (DSM 12397) |
| 09/17/2002 | US6451564 Methods for producing l-isoleucine comprising: (a) growing a transformed nonhuman organism under conditions that provide for synthesis of l-isoleucine, wherein the nonhuman organism comprises one or more copies of a transgene |
| 09/17/2002 | US6451561 Growth hormone variants |
| 09/17/2002 | US6451560 Prokaryotic expression system characterized by alterations to the dlt operon whereby expression of genes encoded therein may be regulated to limit the availability of polypeptides encoded by said genes. |
| 09/17/2002 | US6451559 Expression vector for improved production of polypeptides in yeast |
| 09/17/2002 | US6451557 Method for producing, in yeast, a hydroxylated triple helical protein, and yeast host cells useful in said method |
| 09/17/2002 | US6451554 Purified nucleic acid sequence encoding a sodium channel protein wherein said nucleic acid sequence comprises the coding portion of the nucleic acid sequence and producing a mammalian sensory neuron sodium channel protein, wherein the |
| 09/17/2002 | US6451537 Gene of rice dihydrodipicolinate synthase and DNA relating to the same |
| 09/17/2002 | US6451534 Kvlqt1 and kcne1 which are genes associated with long qt syndrome. additional sequence data for the two genes are also disclosed. mutations in kvlqt1 which result in long qt syndrome. the intron/exon junction sequence data allow for the |
| 09/17/2002 | US6451523 Variant form of the receptor for the obese gene product. the invention relates to methods of detecting this receptor variant in cells and tissues of obese individuals. |
| 09/17/2002 | US6451338 Controlling particle size; foring liposomes, freeze drying, rehydration |
| 09/17/2002 | US6451323 Recombinant newcastle disease virus RNA expression systems and vaccines |
| 09/17/2002 | US6451315 Compounds and methods for the diagnosis and treatment of B. microti infection |
| 09/17/2002 | US6451311 An antibody which binds procalcitonin but not free calcitonin, free katacalcin and free n-procalcitonin; used as an in vitro or in vivo diagnostic agent |
| 09/17/2002 | US6451310 Preventing t cell activation of b cells by administering antibody cabable of binding protein recognized by monoclonal antibody 5c8 |
| 09/17/2002 | US6451256 Recombinant viruses in frozen or liquid form, in which infectious viruses are preserved in an aqueous solution. the recombinant virus suspension comprises an aqueous sucrose solution at a concentration for gene therapy. |
| 09/17/2002 | CA2243459C Human antibodies that bind human tnf.alpha. |
| 09/17/2002 | CA2238640C Non-toxic mutants of pathogenic gram-negative bacteria |
| 09/17/2002 | CA2237767C Process and apparatus for remedying polluted media |
| 09/17/2002 | CA2213001C Isolated nucleic acid molecule encoding peptides which form complexes with mhc molecule hla-cw*1601 and uses thereof |
| 09/17/2002 | CA2187908C Non-splicing variants of gp350/220 |
| 09/17/2002 | CA2095534C Avirulent microbes and uses therefor |
| 09/17/2002 | CA2072420C Storage of materials |
| 09/17/2002 | CA2047244C Genetically engineered immunoglobulins |
| 09/12/2002 | WO2002070757A1 A method for the bacterially assisted heap leaching of chalcopyrite |
| 09/12/2002 | WO2002070737A2 Compositions and methods relating to osteoarthritis |